$1.01
-0.01-0.98%
At close: -
$1.10
0.098.91%
After Hours: 8:51 AM EDT
Comments
Loading...
ProKidney Analyst Ratings and Price Targets | NASDAQ:PROK | Benzinga
ProKidney Corp has a consensus price target of $10.13 based on the ratings of 10 analysts. The high is $18 issued by UBS on October 18, 2022. The low is $3 issued by B of A Securities on September 4, 2024. The 3 most-recent analyst ratings were released by Guggenheim, B of A Securities, and Jefferies on September 10, 2024, September 4, 2024, and June 10, 2024, respectively. With an average price target of $5 between Guggenheim, B of A Securities, and Jefferies, there's an implied 354.55% upside for ProKidney Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Guggenheim
B of A Securities
Jefferies
Morgan Stanley
BTIG
1calculated from analyst ratings
Analyst Ratings for ProKidney
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 09/30/2024 | Buy Now | — | JP Morgan | Anupam Rama60% | — | Initiates | → Neutral | Get Alert |
| 09/10/2024 | Buy Now | 445.45% | Guggenheim | Vamil Divan76% | → $6 | Initiates | → Buy | Get Alert |
| 09/04/2024 | Buy Now | 172.73% | B of A Securities | Jason Gerberry63% | $4 → $3 | Maintains | Neutral | Get Alert |
| 06/10/2024 | Buy Now | 445.45% | Jefferies | Kelly Shi41% | $15 → $6 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | 263.64% | B of A Securities | Jason Gerberry63% | $3 → $4 | Maintains | Neutral | Get Alert |
| 03/07/2024 | Buy Now | 172.73% | Morgan Stanley | Judah Frommer65% | → $3 | Assumes | → Equal-Weight | Get Alert |
| 01/02/2024 | Buy Now | 81.82% | B of A Securities | Jason Gerberry63% | $8 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 07/25/2023 | Buy Now | 1354.55% | BTIG | Justin Zelin41% | → $16 | Initiates | → Buy | Get Alert |
| 12/21/2022 | Buy Now | 1263.64% | Jefferies | Kelly Shi41% | → $15 | Initiates | → Buy | Get Alert |
| 11/10/2022 | Buy Now | 1081.82% | Morgan Stanley | Vikram Purohit38% | → $13 | Initiates | → Equal-Weight | Get Alert |
| 10/18/2022 | Buy Now | 1536.36% | UBS | Colin Bristow41% | → $18 | Initiates | → Buy | Get Alert |
| 10/14/2022 | Buy Now | 1354.55% | Citigroup | Yigal Nochomovitz55% | → $16 | Initiates | → Buy | Get Alert |
| 09/02/2022 | Buy Now | — | Evercore ISI Group | Jonathan Miller10% | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for ProKidney (PROK) stock?
The latest price target for ProKidney (NASDAQ:PROK) was reported by JP Morgan on September 30, 2024. The analyst firm set a price target for $0.00 expecting PROK to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ProKidney (PROK)?
The latest analyst rating for ProKidney (NASDAQ:PROK) was provided by JP Morgan, and ProKidney initiated their neutral rating.
When was the last upgrade for ProKidney (PROK)?
There is no last upgrade for ProKidney
When was the last downgrade for ProKidney (PROK)?
The last downgrade for ProKidney Corp happened on January 2, 2024 when B of A Securities changed their price target from $8 to $2 for ProKidney Corp.
When is the next analyst rating going to be posted or updated for ProKidney (PROK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProKidney, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProKidney was filed on September 30, 2024 so you should expect the next rating to be made available sometime around September 30, 2025.
Is the Analyst Rating ProKidney (PROK) correct?
While ratings are subjective and will change, the latest ProKidney (PROK) rating was a initiated with a price target of $0.00 to $0.00. The current price ProKidney (PROK) is trading at is $1.10, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.